MedPath

A clinical trial of home-based transcutaneous tibial neuromodulation therapy for refractory overactive bladder: a combination therapy with tramadol

Not Applicable
Recruiting
Conditions
Overactive Bladder
Registration Number
JPRN-UMIN000020524
Lead Sponsor
Department of Urology, Faculty of Medical Sciences, University of Fukui
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with cardiac pacemakers 2. Patients with metallic implants inside the stimulation locus 3. Patients with severe heart or lung disease 4. Patients with venous/arterial thrombosis or thrombophlebitis of lower extremities 5. Patients with skin disorder (injury, scar, skin disease, malignancy, etc.) on the stimulation locus 6. Pregnant women 7. Patients with history of convulsion or patients seizures are predicted 8. Patients with excessive post-void residual volume (100 ml or more) 9. Patients with bladder disorders (calculus, cancer, tuberculosis, chronic bacterial cystitis, radiation cystitis, etc.) 10. Any condition which in the judgment of the investigator would place the patient inappropriate to be enrolled in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath